Xirun Medical Secures Nearly RMB 100 Million Series A Funding to Advance Ophthalmic Surgical Platform

Recently, Rhino Health, a developer of high-end ophthalmic surgical equipmentHangzhouRhino Health Medical DeviceHangzhou Xiran Medical Device Technology Co., Ltd. (referred to as "Rhino Health")Completed nearly 100 million yuan in Series A financing.The funds from this round will be used not only for registration and clinical trials but also for the expansion of the R&D pipeline.

# Market Overview

With the rapid development of China's economy and the deepening of the aging process, the demand for diagnosis and treatment of ophthalmic diseases continues to increase.Phacoemulsification and VitrectomyAs the two core procedures in the field of ophthalmic diseases, they cover multiple important indications. Ophthalmic surgical equipment and consumables have high technical barriers. In China, phacoemulsification and vitrectomy surgical devices and consumables have long been monopolized by imported manufacturers, resulting in high costs and a strong demand for domestically produced alternatives.

# Product Overview

Currently, Rhino Health'sGMP FactoryAlready in production, capable of achieving an annual output of one million sets of ophthalmic surgical consumables, meeting market demands both in China and internationally.

The First Phaco-Vitrectomy Integrated Machine GenesisType inspection has been completed, and registration will be submitted within the year. More than 10 types of ophthalmic surgical consumables will be submitted concurrently.

Rhino Health Genesis Product Rendering

# Company Introduction

Rhino Health was founded in 2020 and is aA technology-based ophthalmic surgical equipment manufacturer,An ophthalmic product company that provides one-stop training services for surgeons. Core products include phacoemulsification systems, vitrectomy surgery systems, ultrasound vitrectomy, laser vitrectomy systems, and intraoperative OCT.

As of the date of this report, the company's financing history is as follows:

As of the date of this report, the following partial patent information of the company has been queried: